Applications for funding
Stichting Overleven met Alvleesklierkanker provides funding for research into innovative and effective cancer treatments using oncolytic viruses and immunotherapy, with particular emphasis on pancreatic cancer. The foundation also funds clinical and scientific consortia working in these fields.
Targeted applicants
Clinics or non-medical scientists* with a background or great interest in oncolytic viruses or various forms of immunotherapy.
*Applicants should be medical or non-medical scientists with an appointment for at least the duration of the application process plus the duration of the project at one of the following Dutch knowledge institutions: Dutch universities, university medical centers, Academy and NWO institutes and colleges, researchers of the Netherlands Cancer Institute.
Types of research projects
Funding is available for projects that develop oncolytic viruses or forms of immunotherapy, or that improve understanding of the clinical, pathophysiological, molecular or immunological characteristics of tumours and treatment outcomes. The work should have the potential to improve outcomes for people with aggressive cancers, particularly pancreatic cancer, by developing or refining treatment strategies. Relevant areas include combining immunotherapeutic agents with chemotherapy or oncolytic viruses, dendritic cell therapy, neoantigen vaccines and induced pluripotent stem cells (iPSCs).
Budget: max. EUR 500,000 for 2-4 years. If this budget is exceeded, a reasoned explanation of this overrun should be added. The aim is that projects should have the potential to be further financed, in the event of sufficient success, by larger medical research grant providers such as KWF, NWO and ZonMW.
Assessment
All applications shall be reviewed by the Scientific Advisory Council on the basis of the following assessment criteria:
- alignment with the objectives of Stichting Overleven met Alvleesklierkanker;
- the feasibility and quality of the research proposal;
- the extent to which the candidate's CV fits the research assignment;
- the relationship between budget and tasks to be carried out.
Conditions & Financing
In any event, the research proposal must meet the following conditions:
- the research proposal form is fully completed, i.e. all mandatory fields have been completed and the maximum number of words respected;
- The proposal should clearly indicate that it is a study that will gain more insight into the clinical, patho/physiological, molecular or immunological characteristics of tumours and treatment outcomes;
- the project leader must be promoted at the start of the research and be appointed to a Dutch organisation acting as the main institute;
- a minimum of 1 scientific officer has been appointed for 0.5 fte/month during the duration of the research;
- the budget requested is sufficiently substantiated; maximum funding per research proposal is €500,000. If this budget is exceeded, a reasoned explanation of this overrun should be added.
Before completing your budget request, we ask you to read the financing conditions relating to the costs charged.
Stichting Overleven met Alvleesklierkanker makes a financial contribution and does not normally fund the entire project. Personnel costs for scientific and support staff at participating Dutch or international organisations must be based on the applicable Dutch Universities Collective Labour Agreement and NWO salary scales.
The eligible costs are:- personnel costs and personal budget;
- open access publication costs;
- material costs: (materials specifically necessary for carrying out the research and used for laboratory work and/or deskresearch);
- equipment costs;
- cost service providers.
We encourage applicants to submit a preliminary proposal to avoid unnecessary work. The foundation first checks whether it meets the formal criteria. Eligible preliminary proposals are then assessed by the full Scientific Advisory Council of Stichting Overleven met Alvleesklierkanker.